Cargando…
Significant changes in macrophage and CD8 T cell densities in primary prostate tumors 2 weeks after SBRT
BACKGROUND: Radiotherapy impacts the local immune response to cancers. Prostate Stereotactic Body Radiotherapy (SBRT) is a highly focused method to deliver radiotherapy often used to treat prostate cancer. This is the first direct comparison of immune cells within prostate cancers before and after S...
Autores principales: | Kane, Nathanael, Romero, Tahmineh, Diaz-Perez, Silvia, Rettig, Matthew B., Steinberg, Michael L., Kishan, Amar U., Schaue, Dorthe, Reiter, Robert E., Knudsen, Beatrice S., Nickols, Nicholas G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023555/ https://www.ncbi.nlm.nih.gov/pubmed/35058580 http://dx.doi.org/10.1038/s41391-022-00498-6 |
Ejemplares similares
-
The Intraprostatic Immune Environment after Stereotactic Body Radiotherapy is Dominated by Myeloid Cells
por: Nickols, Nicholas G., et al.
Publicado: (2020) -
Having Your Cake and Eating It Too: Combining SBRT and Multi-agent Chemotherapy in Locally Advanced Pancreatic Cancer
por: Kishan, Amar, et al.
Publicado: (2016) -
Application of a genetic signature of late GU toxicity in SCIMITAR, a Post-op SBRT trial
por: Kishan, Amar U., et al.
Publicado: (2023) -
A Century of Radiation Therapy and Adaptive Immunity
por: Schaue, Dörthe
Publicado: (2017) -
Tumor Size Matters—Understanding Concomitant Tumor Immunity in the Context of Hypofractionated Radiotherapy with Immunotherapy
por: Nesseler, Jean Philippe, et al.
Publicado: (2020)